HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Human immunodeficiency virus (HIV) infects and depletes CD4+ T cells, leading to acquired immunodeficiency syndrome (AIDS).
• The precise mechanisms by which HIV causes T cell dysfunction and depletion are complex and involve direct viral effects and indirect immune dysregulation.

Purpose of the Study:

• To investigate the mechanism of T cell loss during HIV infection.
• To differentiate between the effects of intact HIV and soluble gp120 on T cell function.

Main Methods:

• Antigen-presenting cells (APCs) were pulsed with antigen in the presence of HIV.
• Specific T cells activated by these APCs were assessed using functional assays.
• The effect of soluble gp120, with and without soluble CD4, on antigen-driven T cell proliferation was evaluated.

Main Results:

• Specific T cells, initially stimulated by HIV-pulsed APCs, became undetectable in functional assays.
• This suggests HIV transfer from APCs to T cells via an antigen-dependent mechanism, leading to cytopathic effects.
• Soluble gp120 inhibited antigen-driven T cell proliferation, but this effect was reversible and blocked by soluble CD4.

Conclusions:

• HIV transfer from APCs to activated T cells, mediated by an antigen-dependent mechanism, is a significant factor in T cell loss.
• The gp120/CD4 interaction is likely the primary driver of HIV pathogenesis.
• HIV's pathogenicity may stem mainly from its production of the gp120 envelope protein.